{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-087326","form_type":"8-K","ticker":"CRNX","cik":"0001658247","company_name":"Crinetics Pharmaceuticals, Inc.","filed_at":"2024-04-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.463831+00:00","generated_at":"2026-06-04T02:20:26.495117+00:00","sec_items":["5.02"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Crinetics adopts non-qualified deferred compensation plan for executives and directors","bullets":["Plan effective April 1, 2024; allows deferral of salary, fees, bonuses, and time-based RSUs.","Participation limited to select management, highly compensated employees, and non-employee directors.","Company may make matching or discretionary contributions; elective deferrals and matching fully vested.","Payments generally made after separation from service or at elected in-service payment date."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-087326","json":"https://secwatch.observer/filing/0001193125-24-087326.json","markdown":"https://secwatch.observer/filing/0001193125-24-087326.md","text":"https://secwatch.observer/filing/0001193125-24-087326.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1658247/000119312524087326/0001193125-24-087326-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1658247/000119312524087326/d819564d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T02:20:26.495117+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}